Figure 4.

The prevalence of one or more (DP ≥ 1) and five or more (DP ≥ 5) dispensed drugs in a 3-, 6- and 12- month study period. The prevalence (%) of DP ≥ 1 and DP ≥ 5 in a 3-, 6- and 12- month study period in Sweden in 2006. Number of individuals with DP ≥ 1 in the 3-month period = 4,108,730, in the 6-month period = 5,117,817 and in the 12-month period = 6,146,679. Number of individuals with DP ≥ 5 in the 3-month period = 1,031,397, in the 6-month period = 1,569,180 and in the 12-month period = 2,227,152.